To differentiate synovial cell carcinoma from histiocytic sarcoma, which diagnostic test is required?

To differentiate synovial cell carcinoma from histiocytic sarcoma, which diagnostic test is required?

• A. Radiographs
• B. Ultrasonography
• C. Fine-needle aspiration
• D. Immunohistochemical stains

Answer: (D)

Determining the tumor’s cell lineage to distinguish two similar-looking soft tissue cancers requires immunohistochemical staining. Immunohistochemistry uses antibodies to detect specific proteins expressed by tumor cells, revealing whether the cells behave like epithelial/ synovial-type cells or like histiocytes/macrophages. Synovial sarcoma often expresses epithelial markers such as cytokeratins and epithelial-associated proteins, reflecting its epithelial differentiation, and may show characteristic markers like TLE1 due to its fusion genetics. Histiocytic sarcoma, by contrast, shows histiocytic/macrophage markers such as CD68 and CD163 and typically lacks epithelial markers. This immunoprofile provides decisive evidence about the tumor’s origin, which imaging or cytology alone cannot reliably supply. Imaging studies show location and size but not lineage, and fine-needle aspiration may not capture the full immunophenotype needed for a confident distinction.

Determining the tumor’s cell lineage to distinguish two similar-looking soft tissue cancers requires immunohistochemical staining. Immunohistochemistry uses antibodies to detect specific proteins expressed by tumor cells, revealing whether the cells behave like epithelial/ synovial-type cells or like histiocytes/macrophages. Synovial sarcoma often expresses epithelial markers such as cytokeratins and epithelial-associated proteins, reflecting its epithelial differentiation, and may show characteristic markers like TLE1 due to its fusion genetics. Histiocytic sarcoma, by contrast, shows histiocytic/macrophage markers such as CD68 and CD163 and typically lacks epithelial markers. This immunoprofile provides decisive evidence about the tumor’s origin, which imaging or cytology alone cannot reliably supply. Imaging studies show location and size but not lineage, and fine-needle aspiration may not capture the full immunophenotype needed for a confident distinction.